QUEST DIAGNOSTICS INC (DGX) earnings date
Feb 4, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 52% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 22 days, typically, give or take 7 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Thu, Oct 22, 2026 | before open | 22 | 8-K |
| Q2 FY2026 | Thu, Jul 23, 2026 | before open | 23 | 8-K |
| Q1 FY2026 | Tue, Apr 21, 2026 | before open | 21 | 8-K |
| Q4 FY2025 | Tue, Feb 10, 2026 | before open | 41 | 8-K |
| Q3 FY2025 | Tue, Oct 21, 2025 | before open | 21 | 8-K |
| Q2 FY2025 | Tue, Jul 22, 2025 | before open | 22 | 8-K |
| Q1 FY2025 | Tue, Apr 22, 2025 | before open | 22 | 8-K |
| Q4 FY2024 | Thu, Jan 30, 2025 | before open | 30 | 8-K |
What they guided beta
| Q3 FY2026 | "Document Exhibit 99.1 Quest Diagnostics Reports Third Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026" exhibit |
| Q3 FY2026 | "Full year 2026 revenues now expected to be between $12.065 billion and $12.105 billion" exhibit Read from the sentence: revenue $12.065 billion to $12.105 billion, FY2026 |
| Q3 FY2026 | "Full year 2026 reported diluted EPS now expected to be between $10.21 and $10.31; and adjusted diluted EPS expected to be between $11.25 and $11.35 SECAUCUS, N.J., October 22, 2026 - Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced financial results for the third quarter ended September 30, 2026." exhibit |
| Q3 FY2026 | "Advanced Project Nova from the design phase to the solutions-build phase and continue to expect to deploy Epic solutions in our first lab in the fall of 2027." exhibit |
| Q3 FY2026 | "Additional information will be provided closer to the event. 1 Three Months Ended September 30, Nine Months Ended September 30, 2026 2025 Change 2026 2025 Change (dollars in millions, except per share data) Reported: Net revenues $ 3,097 $ 2,816 10.0 % $ 9,035 $ 8,229 9.8 % Diagnostic Information Services revenues $ 3,035 $ 2,755 10.2 % $ 8,845 $ 8,043 10.0 % Revenue per requisition (4.2) % (2.8) % Requisition volume 14.5 % 12.9 % Organic requisition volume 14.4 % 12.8 % Operating income (a) $ 479 $ 386 24.2 % $ 1,337 $ 1,170 14.3 % Operating income as a percentage of net revenues (a) 15.5 % 1" exhibit |
| Q2 FY2026 | "Document Exhibit 99.1 Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026" exhibit |
| Q2 FY2026 | "Full year 2026 revenues now expected to be between $11.95 billion and $12.05 billion" exhibit Read from the sentence: revenue $11.95 billion to $12.05 billion, FY2026 |
| Q2 FY2026 | "Full year 2026 reported diluted EPS now expected to be between $9.97 and $10.17; and adjusted diluted EPS expected to be between $11.05 and $11.25 SECAUCUS, N.J., July 23, 2026 - Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced financial results for the second quarter ended June 30, 2026." exhibit |
| Q2 FY2026 | "Updated Guidance for Full Year 2026 The company updates its full year 2026 guidance as follows: Updated Guidance Prior Guidance Low High Low High Net revenues $11.95 billion $12.05 billion $11.78 billion $11.90 billion Net revenues increase 8.3% 9.2% 6.8% 7.8% Reported diluted EPS $9.97 $10.17 $9.58 $9.78 Adjusted diluted EPS $11.05 $11.25 $10.63 $10.83 Cash provided by operations Approximately $1.80 billion Approximately $1.75 billion Capital expenditures Approximately $550 million Approximately $550 million Based on the favorable resolution of various tax contingencies in the second quarter," exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/DGX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/DGX
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/DGX/"><img src="https://veritasdata.dev/embed/DGX.svg" alt="DGX earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/DGX/)
Script
<script async src="https://veritasdata.dev/embed/DGX.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/DGX"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.